Additional Information: Known as Levitra in Taiwan, Lidawei Da in Hong Kong, and Ailida in Mainland China, Levitra is an orange pill nicknamed “Flame.” It is a new generation of erectile dysfunction (ED) medication produced by the official Levitra Bayer Medical Care Limited in Germany. Bayer Medical Care Limited, established in 1863 in Germany, is a subsidiary of the Bayer Group, headquartered in Leverkusen, Germany. It is one of the world’s most renowned Fortune Global 500 companies. Bayer has 111,400 employees and 291 branches, almost covering countries worldwide. Pharmaceutical healthcare, materials science, and crop science are the three main pillars of Bayer’s industries. With over 10,000 product varieties, Bayer is Germany’s largest industrial group. Bayer’s history of development is a continuous pursuit of a higher quality of life. On March 6, 1899, Bayer obtained the registered trademark for aspirin, which later became the most widely used and well-known drug brand globally, known as the “Medicine of the Century.”
Bayer Medical Care’s Prescription Drug Division has six sales regions, 12 offices nationwide, and operates in over 70 major cities. It develops, produces, and sells a variety of high-tech patented drugs in the fields of cardiovascular diseases, infections, endocrinology, urology, and more. Some of its key products include Glucobay for diabetes treatment, Avelox as an antibiotic, AdalatGITS for cardiovascular diseases, Bayaspirin100mg, and Levitra for the treatment of male erectile dysfunction (ED). Bayer’s pharmaceutical factory is located in the Beijing Economic and Technological Development Zone, covering an area of 36,000 square meters. The factory, constructed between 1995 and 1997, produces solid and ointment drugs within the scope of its production license. Additionally, the factory handles the packaging of injectable drugs. Currently, the factory has 15 production lines, with 13 dedicated to production and packaging and two for importing finished products.
Bayer markets Levitra in the Greater China region, primarily targeting Hong Kong, Taiwan, and mainland China. Bayer Group Greater China is led by a holding company, overseeing independent operations of subsidiaries and joint venture production enterprises. As a first-line drug for treating ED, Levitra has been officially launched in 77 countries worldwide, with licenses obtained in 82 countries. Clinical trial data and actual usage demonstrate that Levitra is a reliable ED treatment. With its faster onset time and more sustained and reliable therapeutic effects, Levitra brings a higher quality of life to ED patients in Hong Kong and worldwide.
Levitra is a highly potent PDE-5 inhibitor, and its effectiveness is recognized by global male experts as a safe, healthy, and efficient ED treatment with no side effects. Levitra not only improves the quality of sexual life but also has an immediate effect on prolonging intercourse, as confirmed by consumers who have personally experienced its effects. Levitra has a reasonable time window for use, and the majority of users experience satisfactory results the first time they use the medication. Furthermore, the duration of the therapeutic effect can last up to 12 hours, providing a perfect sexual life from the evening of the day of use to the next morning.
Levitra, a type of drug that mainly functions by inhibiting phosphodiesterase type 5 (PDE5) in the penile corpus cavernosum, enhances the release of endogenous nitric oxide in the corpus cavernosum under sexual stimulation. This stimulation leads to natural erection, making it easier for patients to achieve higher hardness, significantly superior to other similar products. The advantages of Levitra include its high potency, selectivity, rapid onset, long-term reliability, good tolerance, and independence from diet restrictions. Levitra is a suitable choice for diabetic ED patients, with over 70% of such patients showing a significant improvement in erection after taking the drug.
Levitra significantly improves the satisfaction of both partners in sexual intercourse. A recent study indicated that after 12 weeks of Levitra treatment, both partners of ED patients were satisfied with the therapeutic effects, enhancing their satisfaction with erection function, sexual intercourse, and climax, boosting their confidence in sexual function.
Levitra has demonstrated good tolerance, with most adverse reactions being mild. The most common side effects include headache, facial flushing, and nasal congestion—typical side effects of PDE5 inhibitors. Clinical trials in China have shown that the incidence of nasal congestion among Chinese is lower than that of Caucasians, possibly due to racial differences or other factors. Clinically proven, Levitra can improve erectile function, even if patients have other health factors such as high cholesterol, hypertension, or diabetes. Levitra helps ED patients regain a happy sexual life, making it a well-established and effective treatment for erectile dysfunction patients!